Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vijithan Sugumar"'
Autor:
Michael Yan, Tzen S. Toh, Patricia E. Lindsay, Jessica Weiss, Katrina Hueniken, Christy Yeung, Vijithan Sugumar, Dixon Pinto, Tony Tadic, Alexander Sun, Andrea Bezjak, John Cho, Srinivas Raman, Meredith Giuliani, Fabio Ynoe Moraes, Geoffrey Liu, Andrew J. Hope, Benjamin H. Lok
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss , Pp 43-49 (2021)
Background & purpose: Prophylactic cranial irradiation (PCI) is recommended for limited-stage small-cell lung cancer (LS-SCLC) patients with good response to concurrent chemoradiation. We report our institution’s 20-year experience with this patien
Externí odkaz:
https://doaj.org/article/ad5f585c02a14ef5890c8edacd90a47b
Autor:
Annie Ren, Ioannis Prassas, Vijithan Sugumar, Antoninus Soosaipillai, Marcus Bernardini, Eleftherios P Diamandis, Vathany Kulasingam
Publikováno v:
F1000Research, Vol 10 (2021)
Background: In this pilot study, we perform a preliminary comparison of two targeted multiplex proteomics technologies for discerning serum protein concentration changes that may correlate to tumor burden in ovarian cancer (OC) patients. Methods: Usi
Externí odkaz:
https://doaj.org/article/045f91375fa54c209514b1ea178c2d6f
Autor:
Michael Yan, Samantha Sigurdson, Noah Greifer, Thomas A. C. Kennedy, Tzen S. Toh, Patricia E. Lindsay, Jessica Weiss, Katrina Hueniken, Christy Yeung, Vijithan Sugumar, Alexander Sun, Andrea Bezjak, B. C. John Cho, Srinivas Raman, Andrew J. Hope, Meredith E. Giuliani, Elizabeth A. Stuart, Timothy Owen, Allison Ashworth, Andrew Robinson, Fabio Ynoe de Moraes, Geoffrey Liu, Benjamin H. Lok
Publikováno v:
Cancers, Vol 13, Iss 12, p 2895 (2021)
Despite evidence for the superiority of twice-daily (BID) radiotherapy schedules, their utilization in practice remains logistically challenging. Hypofractionation (HFRT) is a commonly implemented alternative. We aim to compare the outcomes and toxic
Externí odkaz:
https://doaj.org/article/816222ba11bf43a2899ac4812ad43b7f
Autor:
Benjamin H. Lok, Geoffrey Liu, Ming S. Tsao, Aaron D. Schimmer, Rod Bremner, Joel D. Pearson, Samir H. Barghout, Vijithan Sugumar, Ranya Barayan, Jessica Weiss, Lifang Song, Fariha Rahman, Vidhyasagar Venkatasubramanian, Kevin C.J. Nixon, Mansi K. Aparnathi, Safa Majeed
Supplementary Data from Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07dec1598a9f1c977852b1ad0084664a
https://doi.org/10.1158/1078-0432.22483878.v1
https://doi.org/10.1158/1078-0432.22483878.v1
Autor:
Benjamin H. Lok, Geoffrey Liu, Ming S. Tsao, Aaron D. Schimmer, Rod Bremner, Joel D. Pearson, Samir H. Barghout, Vijithan Sugumar, Ranya Barayan, Jessica Weiss, Lifang Song, Fariha Rahman, Vidhyasagar Venkatasubramanian, Kevin C.J. Nixon, Mansi K. Aparnathi, Safa Majeed
Purpose:Small cell lung cancer (SCLC) is an aggressive disease with an overall 5-year survival rate of less than 10%. Treatment for SCLC with cisplatin/etoposide chemotherapy (C/E) ± radiotherapy has changed modestly over several decades. The ubiqui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62960533f4307a56243682fafcc1f621
https://doi.org/10.1158/1078-0432.c.6531261.v1
https://doi.org/10.1158/1078-0432.c.6531261.v1
Autor:
Safa Majeed, Mansi K. Aparnathi, Kevin C.J. Nixon, Vidhyasagar Venkatasubramanian, Fariha Rahman, Lifang Song, Jessica Weiss, Ranya Barayan, Vijithan Sugumar, Samir H. Barghout, Joel D. Pearson, Rod Bremner, Aaron D. Schimmer, Ming S. Tsao, Geoffrey Liu, Benjamin H. Lok
Publikováno v:
Clinical Cancer Research. 28:1966-1978
Purpose: Small cell lung cancer (SCLC) is an aggressive disease with an overall 5-year survival rate of less than 10%. Treatment for SCLC with cisplatin/etoposide chemotherapy (C/E) ± radiotherapy has changed modestly over several decades. The ubiqu
Autor:
Meredith Giuliani, Patricia Lindsay, Jessica Weiss, Alexander Sun, Michael Yan, Benjamin H. Lok, Geoffrey Liu, Christy Yeung, Tzen S. Toh, Tony Tadic, Andrea Bezjak, Srinivas Raman, Katrina Hueniken, Vijithan Sugumar, Fabio Y. Moraes, Andrew Hope, John Cho, Dixon Pinto
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 43-49 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Prophylactic cranial irradiation (PCI) was more commonly used in younger patients. • PCI utilization rates did not change throughout our 20-year institutional experience. • PCI was associated with improved OS and lower brain metast
Autor:
Annie Ren, Marcus Q. Bernardini, Eleftherios P. Diamandis, Ioannis Prassas, Antoninus Soosaipillai, Vathany Kulasingam, Vijithan Sugumar
Publikováno v:
F1000Research
Background: In this pilot study, we perform a preliminary comparison of two targeted multiplex proteomics technologies for discerning serum protein concentration changes that may correlate to tumor burden in ovarian cancer (OC) patients. Methods: Usi
Autor:
Fabio Y. Moraes, G. Liu, Andrew Hope, Michael Yan, Katrina Hueniken, Elizabeth A. Stuart, Christy Yeung, T. Kennedy, Andrea Bezjak, Srinivas Raman, A.G. Robinson, Alexander Sun, Allison Ashworth, Timothy Owen, Noah Greifer, Meredith Giuliani, John Cho, Tzen S. Toh, Benjamin H. Lok, Vijithan Sugumar, Samantha Sigurdson, Patricia Lindsay, Jessica Weiss
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e469-e470
PURPOSE/OBJECTIVE(S) Despite evidence for the superiority of twice daily (BID) radiotherapy schedules, their utilization in practice remains logistically challenging. Hypofractionation (HFRT) is a commonly implemented alternative. We aim to compare t
Publikováno v:
Journal of clinical pathology. 73(2)
Mass spectrometry-based assays have been increasingly implemented in various disciplines in clinical diagnostic laboratories for their combined advantages in multiplexing capacity and high analytical specificity and sensitivity. It is now routinely u